RadNet, Inc. (NASDAQ:RDNT) Stock Holdings Decreased by LMR Partners LLP

LMR Partners LLP trimmed its position in shares of RadNet, Inc. (NASDAQ:RDNT - Free Report) by 72.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,873 shares of the medical research company's stock after selling 18,203 shares during the quarter. LMR Partners LLP's holdings in RadNet were worth $480,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in RDNT. Vanguard Group Inc. grew its position in RadNet by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 7,425,218 shares of the medical research company's stock worth $518,577,000 after buying an additional 71,910 shares during the period. Invesco Ltd. grew its position in shares of RadNet by 4.3% in the fourth quarter. Invesco Ltd. now owns 1,731,074 shares of the medical research company's stock valued at $120,898,000 after purchasing an additional 70,673 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in shares of RadNet by 30.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,475,995 shares of the medical research company's stock valued at $103,532,000 after purchasing an additional 344,146 shares during the last quarter. Hood River Capital Management LLC boosted its position in RadNet by 3.1% during the fourth quarter. Hood River Capital Management LLC now owns 1,322,879 shares of the medical research company's stock worth $92,390,000 after acquiring an additional 39,881 shares during the last quarter. Finally, Marshall Wace LLP boosted its position in RadNet by 11.5% during the fourth quarter. Marshall Wace LLP now owns 1,222,690 shares of the medical research company's stock worth $85,393,000 after acquiring an additional 125,844 shares during the last quarter. 77.90% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently issued reports on RDNT shares. StockNews.com upgraded shares of RadNet to a "sell" rating in a research report on Monday, May 12th. Raymond James upgraded shares of RadNet from an "outperform" rating to a "strong-buy" rating and decreased their target price for the stock from $85.00 to $65.00 in a research report on Wednesday, March 5th. Truist Financial decreased their target price on shares of RadNet from $88.00 to $74.00 and set a "buy" rating on the stock in a research report on Friday, April 11th. Finally, Barclays decreased their target price on shares of RadNet from $74.00 to $60.00 and set an "overweight" rating on the stock in a research report on Monday, March 24th. One research analyst has rated the stock with a sell rating, three have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Buy" and an average price target of $69.75.

Insider Activity at RadNet

In other RadNet news, CEO Cornelis Wesdorp sold 1,000 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $50.52, for a total value of $50,520.00. Following the transaction, the chief executive officer now owns 55,995 shares in the company, valued at $2,828,867.40. The trade was a 1.75% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Norman R. Hames sold 5,536 shares of the business's stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $60.00, for a total transaction of $332,160.00. Following the completion of the transaction, the chief operating officer now owns 249,183 shares in the company, valued at $14,950,980. This represents a 2.17% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 46,447 shares of company stock worth $2,433,550. 5.12% of the stock is currently owned by corporate insiders.

RadNet Trading Down 1.3%

NASDAQ:RDNT traded down $0.80 during trading hours on Tuesday, reaching $59.86. 40,772 shares of the company were exchanged, compared to its average volume of 681,357. The stock has a 50 day simple moving average of $51.98 and a 200 day simple moving average of $63.09. RadNet, Inc. has a 52-week low of $45.00 and a 52-week high of $93.65. The company has a debt-to-equity ratio of 0.89, a current ratio of 2.16 and a quick ratio of 2.16. The firm has a market cap of $4.49 billion, a price-to-earnings ratio of -856.31 and a beta of 1.46.

RadNet (NASDAQ:RDNT - Get Free Report) last posted its earnings results on Thursday, February 27th. The medical research company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.01. The business had revenue of $477.10 million for the quarter, compared to analyst estimates of $459.42 million. RadNet had a negative net margin of 0.25% and a positive return on equity of 4.29%. As a group, analysts predict that RadNet, Inc. will post 0.56 EPS for the current year.

RadNet Company Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.